Carl Zeiss Meditec AG (AFX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Carl Zeiss Meditec AG (AFX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011719
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of eye diseases including implants and consumable materials. Its major products include medical laser and diagnostic systems, intraocular lenses and consumables for ophthalmic surgery. The company products find application in diagnosis, monitoring and follow up treatment of various diseases of the eye diseases. The company products are marketed through distribution companies and agencies in Europe, the Americas and Asia-Pacific. Carl Zeiss Meditec is headquartered in Jena, Germany.

Carl Zeiss Meditec AG (AFX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Carl Zeiss Meditec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Carl Zeiss Meditec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Carl Zeiss Meditec AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Carl Zeiss Meditec AG, Medical Equipment, Deal Details 11
Asset Purchase 11
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Carl Zeiss Meditec Acquires Intraocular lens And Viscoelastic Devices Business From Imex Clinic, For US$23.2 Million 12
Partnerships 13
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 13
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 14
Equity Offering 15
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 15
Acquisition 16
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 16
Carl Zeiss Meditec Acquires Optronik 17
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 18
Carl Zeiss Meditec AG – Key Competitors 19
Carl Zeiss Meditec AG – Key Employees 20
Carl Zeiss Meditec AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Strategy And Business Planning 23
Apr 25, 2017: ZEISS Opens New Microscopy Customer Center 23
Oct 26, 2016: ZEISS Invests Further 60 Million Euros in the Expansion of the Semiconductor Manufacturing Technology Factory 24
Financial Announcements 25
Dec 08, 2017: Carl Zeiss Meditec grows by 9% in fiscal year 2016/17 25
May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 27
Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 28
Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 29
Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 30
Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 31
May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 32
Apr 29, 2016: ZEISS on Course to Further Growth 33
Apr 04, 2016: Carl Zeiss Meditec achieves revenue growth of approximately 9% in first half year 2015/16 34
Feb 12, 2016: Carl Zeiss Meditec Grows, Boosted by Currency Tailwinds / Strongest Growth Once Again in Surgical Ophthalmology 35
Feb 12, 2016: Carl Zeiss Meditec is again growing in the ophthalmology of the ophthalmology sector with a backwind of currency effects / strongest growth 36
Corporate Communications 38
Jun 29, 2017: New management for the ZEISS Consumer Optics division 38
May 08, 2017: ZEISS Appoints New Fellow 39
Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 40
Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 41
Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 42
Legal and Regulatory 43
May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 43
Mar 27, 2017: Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme 44
Product News 45
Dec 04, 2017: New field emission scanning electron microscope ZEISS GeminiSEM 450 introduced 45
Nov 15, 2017: New 2D Superresolution mode for ZEISS Airyscan delivers 120 nanometer lateral resolution 46
Nov 11, 2017: ZEISS unveils digitalization and diagnostic advancements for eye care at AAO 2017 47
May 10, 2017: ZEISS is Presenting the SMILE Laser Correction, which Revitalises the US Market for Refractive Surgery, as well as the SWEPT Source Biometry with the Barrett Suite 49
May 08, 2017: At ASCRS 2017, ZEISS showcases SMILE laser vision correction, set to reinvigorate the US refractive surgery market, and SWEPT Source Biometry with the Barrett Suite for reducing the risk of refractive surprises 52
May 08, 2017: Open Innovation of ZEISS and the Advanced Retina Imaging Network advances Swept-Source OCT technology for better vision care 54
Oct 26, 2016: New ZEISS Axio Observer Microscopes for Life Science 55
May 03, 2016: ZEISS introduces Fast acquisition mode for ZEISS LSM 880 with Airyscan 56
Apr 29, 2016: ZEISS Receives CE Mark Approval for PLEX Elite 9000 Swept-Source OCT 57
02/09/2016: Zeiss AngioPlex Optical Coherence Tomography Angiography of the Retinal Microvasculature May Help Enhance Understanding of Retinal Disease 58
Other Significant Developments 59
Aug 07, 2017: Carl Zeiss Meditec continues its growth path 59
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Carl Zeiss Meditec AG, Medical Equipment, Key Facts, 2016 2
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Carl Zeiss Meditec AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Carl Zeiss Meditec AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Carl Zeiss Meditec AG, Deals By Market, 2011 to YTD 2017 9
Carl Zeiss Meditec AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Carl Zeiss Meditec Acquires Intraocular lens And Viscoelastic Devices Business From Imex Clinic, For US$23.2 Million 12
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 13
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 14
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 15
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 16
Carl Zeiss Meditec Acquires Optronik 17
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 18
Carl Zeiss Meditec AG, Key Competitors 19
Carl Zeiss Meditec AG, Key Employees 20
Carl Zeiss Meditec AG, Subsidiaries 21

★海外企業調査レポート[Carl Zeiss Meditec AG (AFX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Roquette Freres S.A.(環境技術分野):企業M&A動向
    Summary Roquette Freres S.A. (Roquette) is a manufacturer of starch and starch derivatives. It offers around 700 products and solutions. The company’s product portfolio includes starch products, sugars and dietary fibers, polyols, derivatives of fermentation, proteins and their derivatives, fibers, …
  • Elmet Technologies, Inc.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Elmet Technologies, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Teva Pharmaceutical Industries Limited (TEVA):企業の財務及び戦略的SWOT分析
    Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Enea S.A. (ENA):企業のM&A・提携動向(発電分野)
    Summary Enea S.A. (Enea) is provider of energy that conducts the generation, transmission, purchase and sale of electricity; production and distribution of heat; production and sale of bituminous coal; and maintenance and modernization of road lighting equipment, transport, construction services, tr …
  • Gujarat Ambuja Exports Ltd (GAEL):企業財務及び戦略的SWOT分析
    Summary Gujarat Ambuja Exports Ltd (GAEL) is an agro product supplier that offers grains processing services. The company exports agro based products to various markets. It distributes products, which include cotton yarn, de-oiled cake, refined edible oil, vanaspati ghee, cattle feed, wheat floor, s …
  • OJSC Magnitogorsk Iron and Steel Works:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OJSC Magnitogorsk Iron and Stee …
  • Bill Barrett Corporation (BBG):企業のM&A・提携動向(石油・ガス分野)
    Summary Bill Barrett Corporation (BBC) is an oil and gas company that purchases, explores, develops and produces crude oil and natural gas. The company has operations in development areas which include Gibson Gulch area in the Piceance Basin, the Uinta Oil Program in the Uinta Basin, and oil program …
  • Abcodia Ltd:企業のM&A・提携動向(医療機器分野)
    Summary Abcodia Ltd (Abcodia) is a biotechnology company that offers molecular biomarker validation services. The company validates and discovers biomarkers for early diagnosis and screening of cancer. It concentrates in the detection of breast cancer, colorectal cancer, pancreatic cancer, lung canc …
  • Sloman Neptun Schiffahrts-AG (NEP):企業の財務及び戦略的SWOT分析
    Summary SLOMAN NEPTUN Schiffahrts-Aktiengesellschaft (SLOMAN NEPTUN) is an oil and gas company that offers shipping services. The company provides transportation of global gas and oil products. It operates modern tankers, multipurpose vessels that connect North Africa and other Mediterranean ports w …
  • Chemed Corporation (CHE):企業の財務及び戦略的SWOT分析
    Summary Chemed Corporation (Chemed) is a healthcare service provider that offers hospice services. The company operates through its two business subsidiaries such as VITAS Healthcare Corporation and Roto-Rooter. Its VITAS Healthcare Corporation provides end-of-life hospice care for heart disease, st …
  • Space Exploration Technologies Corp:戦略・SWOT・企業財務分析
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • eGain Communications Corporation (EGAN):企業の財務及び戦略的SWOT分析
    Summary eGain Communications Corporation (eGain) is an information technology company that develops customer engagement platform. The company offers products that include eGain case manager, eGain chat, eGain clicktocall, eGain cobrowse, eGain community, eGain consulting, eGain virtual assistant, eG …
  • Nexter Group(航空・防衛):企業概要、SWOT分析
    Summary SDI's "Nexter Group: Aerospace and Defense - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, ke …
  • Mapletree Commercial Trust:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Mapletree Commercial Trust" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • HTC Corporation:企業のM&A・提携・投資分析
    HTC Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HTC Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Genworth Financial, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Genworth Financial, Inc. Merger …
  • Suez Environnement SA (SEV):企業財務及び戦略的SWOT分析
    Summary Suez Environnement SA (Suez Environnement) a subsidiary of GDF Suez is a clean technology company that offers drinking water solutions. The company offers water management, recycling and waste recovery and urban development services. It offers water management services such as collection and …
  • Threshold Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Threshold Pharmaceuticals, Inc. …
  • Opta Minerals, Inc. (OPM):企業概要、財務及び戦略的SWOT分析
    Summary Opta Minerals, Inc. (OM) is an industrial minerals provider. The company processes, distributes and sells industrial minerals, silica-free loose abrasives, and specialty sands and related products. Its product categories include blast cleaning abrasive products, blast cleaning equipment, con …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆